TrialNeurology(R) neuroimmunology & neuroinflammation2021

Serum Neurofilament Levels and PML Risk in Patients With Multiple Sclerosis Treated With Natalizumab.

Nicolás Fissolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.